Loading...
LifeStance Health Group, Inc.
LFST•NASDAQ
Healthcare
Medical - Care Facilities
$4.14
$0.00(0.00%)
LifeStance Health Group, Inc. (LFST) Financial Performance & Income Statement Overview
Review LifeStance Health Group, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.50%
↑ 18.50%
Operating Income Growth
83.29%
↑ 83.29%
Net Income Growth
69.16%
↑ 69.16%
Operating Cash Flow Growth
735.28%
↑ 735.28%
Operating Margin
-1.00%
↓ 1.002%
Gross Margin
29.93%
↑ 29.93%
Net Profit Margin
-2.78%
↓ 2.78%
ROE
-2.47%
↓ 2.47%
ROIC
-0.68%
↓ 0.68%
LifeStance Health Group, Inc. (LFST) Income Statement & Financial Overview
Review LifeStance Health Group, Inc.'s (LFST) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $325.48M | $312.72M | $312.33M | $300.44M |
| Cost of Revenue | $216.04M | $212.29M | $233.13M | $228.28M |
| Gross Profit | $109.44M | $100.43M | $79.21M | $72.16M |
| Gross Profit Ratio | $0.34 | $0.32 | $0.25 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $93.71M | $85.27M | $94.77M | $88.84M |
| Operating Expenses | $108.38M | $100.38M | $94.77M | $88.84M |
| Total Costs & Expenses | $324.42M | $312.68M | $327.90M | $317.11M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $9.40M | $5.41M | $5.82M | $5.90M |
| Depreciation & Amortization | $14.67M | $15.12M | $18.60M | $22.56M |
| EBITDA | $15.19M | $15.15M | $1.80M | $7.73M |
| EBITDA Ratio | $0.05 | $0.05 | $0.006 | $0.03 |
| Operating Income | $1.06M | $47000.00 | -$15.57M | -$16.68M |
| Operating Income Ratio | $0.003 | $0.00 | -$0.05 | -$0.06 |
| Other Income/Expenses (Net) | -$9.94M | -$5.43M | -$6.67M | -$3.96M |
| Income Before Tax | -$8.88M | -$5.38M | -$22.62M | -$20.73M |
| Income Before Tax Ratio | -$0.03 | -$0.02 | -$0.07 | -$0.07 |
| Income Tax Expense | -$1.76M | $575000.00 | $656000.00 | $363000.00 |
| Net Income | -$7.11M | -$5.96M | -$23.28M | -$21.10M |
| Net Income Ratio | -$0.02 | -$0.02 | -$0.07 | -$0.07 |
| EPS | -$0.02 | -$0.02 | -$0.06 | -$0.06 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.06 | -$0.06 |
| Weighted Avg Shares Outstanding | $382.74M | $378.71M | $379.43M | $376.33M |
| Weighted Avg Shares Outstanding (Diluted) | $382.74M | $378.71M | $379.43M | $376.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan